Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00245271 · ClinicalTrials.gov registry record · Phase 3

Safety of OMS103HP in Patients Undergoing Anterior Cruciate Ligament (ACL) Reconstruction

A Phase 3 study of Anterior Cruciate Ligament Reconstruction, sponsored by Omeros Corporation.

Completed
Registry status
Phase 3
Development phase
480
Enrollment target
10
Study locations

NCT00245271 is a Phase 3 study of Anterior Cruciate Ligament Reconstruction that has completed, run by Omeros Corporation. The registered enrollment target is 480 participants, above the 251-participant average among 11 other Anterior Cruciate Ligament Reconstruction trials with a reported enrollment target (91% higher). The trial reports 10 study locations across 6 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00245271, a Phase 3 study of Anterior Cruciate Ligament Reconstruction, has completed, sponsored by Omeros Corporation.

COMPLETED
Registry status
Phase 3
Development phase
480 participants
Enrollment target
10
Study locations

Study Summary

OMS103HP is being developed for improvement in knee function following ACL reconstruction. Secondary benefits being evaluated include reduced postoperative pain, improvement in knee motion and earlier return to work.

Conditions Studied

Anterior Cruciate Ligament Reconstruction

Interventions

  • DRUG Vehicle
  • DRUG OMS103HP

Study Locations (10)

California

  • Kerlan-Jobe Orthopaedic Clinic - Los Angeles
  • Sports, Orthopedic and Rehabilitation Medicine Associates (S.O.A.R.) - Redwood City

Colorado

  • Advanced Orthopedic and Sports Medicine Specialists - Denver
  • Colorado Orthopedic Consultants, PC - Englewood

North Carolina

  • Duke University - Durham
  • Wake Forest University Health Sciences - Winston-Salem

Pennsylvania

  • Temple University Orthopedics - Philadelphia
  • University of Pittsburgh Medical Center - Pittsburgh

Illinois

  • Rush University - Chicago

Ohio

  • Ohio State University Sports Medicine - Columbus

Trial Details

FieldValue
Enrollment Target 480 participants
Start Date 2004-10
Est. Completion 2011-03
Phase Phase 3

Sponsor

Omeros Corporation

19 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00245271

The ClinicalTrials.gov registry entry for NCT00245271 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 480 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 251-participant average among 11 other Anterior Cruciate Ligament Reconstruction trials with a reported enrollment target (91% higher). The listed sponsor is Omeros Corporation, which has 19 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Anterior Cruciate Ligament Reconstruction appearing as the primary indexed condition, and to 2 interventions - of which Vehicle is the first listed.

NCT00245271 reports 10 study locations spanning 6 distinct geographic areas - top geographies include California, Colorado, North Carolina.

Frequently Asked Questions

What is clinical trial NCT00245271 about?

NCT00245271 is a clinical study titled "Safety of OMS103HP in Patients Undergoing Anterior Cruciate Ligament (ACL) Reconstruction". OMS103HP is being developed for improvement in knee function following ACL reconstruction. Secondary benefits being evaluated include reduced postoperative pain, improvement in knee motion and earlier return to work.

What is the current status of trial NCT00245271?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 480 participants. The study started on 2004-10. Estimated completion is 2011-03.

What conditions does trial NCT00245271 study?

This clinical trial studies the following conditions: Anterior Cruciate Ligament Reconstruction.

What interventions are being tested in trial NCT00245271?

The interventions under investigation include: Vehicle (DRUG), OMS103HP (DRUG).

Who is sponsoring clinical trial NCT00245271?

This trial is sponsored by Omeros Corporation, which has 19 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00245271 being conducted?

This trial has 10 study locations across California, Colorado, Illinois, North Carolina, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Anterior Cruciate Ligament Reconstruction

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Anterior Cruciate Ligament Reconstruction

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.